Knut T. Smerud

1.0k total citations
30 papers, 772 citations indexed

About

Knut T. Smerud is a scholar working on Pulmonary and Respiratory Medicine, Social Psychology and Nephrology. According to data from OpenAlex, Knut T. Smerud has authored 30 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Social Psychology and 5 papers in Nephrology. Recurrent topics in Knut T. Smerud's work include Neuroendocrine regulation and behavior (8 papers), Cystic Fibrosis Research Advances (5 papers) and Evolutionary Psychology and Human Behavior (5 papers). Knut T. Smerud is often cited by papers focused on Neuroendocrine regulation and behavior (8 papers), Cystic Fibrosis Research Advances (5 papers) and Evolutionary Psychology and Human Behavior (5 papers). Knut T. Smerud collaborates with scholars based in Norway, United Kingdom and Sweden. Knut T. Smerud's co-authors include Ole A. Andreassen, Per G. Djupesland, Daniel Quintana, Lars T. Westlye, Ramy Mahmoud, Lars H. Høie, Serena Tonstad, Øyvind G. Rustan, Tobias Kaufmann and Dag Alnæs and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Clinical Nutrition and Biological Psychiatry.

In The Last Decade

Knut T. Smerud

29 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Knut T. Smerud Norway 15 329 148 126 113 80 30 772
Falko H. Herrmann Germany 17 237 0.7× 110 0.7× 32 0.3× 36 0.3× 20 0.3× 43 1.1k
Marina Pontillo Italy 12 149 0.5× 81 0.5× 40 0.3× 32 0.3× 28 0.3× 35 915
Anne Vincent France 19 84 0.3× 7 0.0× 134 1.1× 32 0.3× 104 1.3× 67 954
Domenico Canale Italy 15 100 0.3× 80 0.5× 16 0.1× 5 0.0× 48 0.6× 44 923
A. Marcato Italy 12 67 0.2× 24 0.2× 63 0.5× 5 0.0× 31 0.4× 26 763
Sten Rosberg Sweden 21 58 0.2× 18 0.1× 134 1.1× 9 0.1× 32 0.4× 50 1.7k
Jill D. Jacobson United States 17 101 0.3× 7 0.0× 49 0.4× 16 0.1× 55 0.7× 42 893
Michael S. Goldrich United States 11 68 0.2× 15 0.1× 167 1.3× 16 0.1× 8 0.1× 12 1.1k
C. Almerighi Italy 12 57 0.2× 45 0.3× 23 0.2× 3 0.0× 179 2.2× 21 1.2k

Countries citing papers authored by Knut T. Smerud

Since Specialization
Citations

This map shows the geographic impact of Knut T. Smerud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Knut T. Smerud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Knut T. Smerud more than expected).

Fields of papers citing papers by Knut T. Smerud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Knut T. Smerud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Knut T. Smerud. The network helps show where Knut T. Smerud may publish in the future.

Co-authorship network of co-authors of Knut T. Smerud

This figure shows the co-authorship network connecting the top 25 collaborators of Knut T. Smerud. A scholar is included among the top collaborators of Knut T. Smerud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Knut T. Smerud. Knut T. Smerud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nielsen, Dorte, Erik Jakobsen, Sven Tyge Langkjer, et al.. (2023). Predictive biomarker for cisplatin in prospective phase 2 of liposomal cisplatin in metastatic breast cancer.. Journal of Clinical Oncology. 41(16_suppl). 3130–3130.
2.
Godang, Kristin, Trine Finnes, Knut T. Smerud, et al.. (2023). Trabecular Bone Score Improves Early After Successful Kidney Transplantation Irrespective of Antiresorptive Therapy and Changes in Bone Mineral Density. Transplantation Direct. 10(1). e1566–e1566. 1 indexed citations
3.
Albertsson, Per, Tom Bäck, Karin Bergmark, et al.. (2023). Astatine-211 based radionuclide therapy: Current clinical trial landscape. Frontiers in Medicine. 9. 1076210–1076210. 49 indexed citations
4.
Schwarz, C., Rebecca Weiser, Eshwar Mahenthiralingam, et al.. (2022). Evaluating the alginate oligosaccharide (OligoG) as a therapy for Burkholderia cepacia complex cystic fibrosis lung infection. Journal of Cystic Fibrosis. 21(5). 821–829. 12 indexed citations
5.
Quintana, Daniel, Lars T. Westlye, Knut T. Smerud, et al.. (2018). Saliva oxytocin measures do not reflect peripheral plasma concentrations after intranasal oxytocin administration in men. Hormones and Behavior. 102. 85–92. 41 indexed citations
6.
Quintana, Daniel, Lars T. Westlye, Dag Alnæs, et al.. (2018). Low-dose intranasal oxytocin delivered with Breath Powered device modulates pupil diameter and amygdala activity: a randomized controlled pupillometry and fMRI study. Neuropsychopharmacology. 44(2). 306–313. 26 indexed citations
7.
Pihlstrøm, Hege, Andreas Pasch, Hallvard Holdaas, et al.. (2018). Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score. BMC Nephrology. 19(1). 212–212. 6 indexed citations
8.
Smerud, Knut T., Anders Åsberg, Andreas Pasch, et al.. (2017). A rapid and sustained improvement of calcification propensity score (serum T50) after successful kidney transplantation: Reanalysis of a randomized controlled trial of ibandronate. Clinical Transplantation. 31(12). 5 indexed citations
9.
10.
11.
Pressler, T., Scott H. Donaldson, Knut T. Smerud, & Astrid Hilde Myrset. (2017). WS01.3 A double blind, randomised, placebo-controlled cross over study of inhaled alginate oligosaccharide (OligoG) administered for 28 days in subjects with cystic fibrosis. Journal of Cystic Fibrosis. 16. S1–S2. 3 indexed citations
12.
Quintana, Daniel, Lars T. Westlye, Knut T. Smerud, et al.. (2016). Reliability of basal plasma vasopressin concentrations in healthy male adults. Acta Neuropsychiatrica. 29(5). 315–321. 7 indexed citations
13.
14.
Kantola, Ilkka, et al.. (2016). Safety, Tolerability, and Antihypertensive Effect of SER100, an Opiate Receptor‐Like 1 (ORL‐1) Partial Agonist, in Patients With Isolated Systolic Hypertension. Clinical Pharmacology in Drug Development. 6(6). 584–591. 14 indexed citations
15.
Quintana, Daniel, Lars T. Westlye, Øyvind G. Rustan, et al.. (2015). Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment. Translational Psychiatry. 5(7). e602–e602. 85 indexed citations
16.
Rollefstad, Silvia, Eirik Ikdahl, Jonny Hisdal, et al.. (2014). Rosuvastatin induced carotid plaque regression in patients with inflammatory joint diseases. Atherosclerosis. 235(2). e93–e93. 4 indexed citations
17.
Tvete, Ingunn Fride, Inge Christoffer Olsen, Morten Wang Fagerland, et al.. (2012). An approach to combining parallel and cross-over trials with and without run-in periods using individual patient data. Clinical Trials. 9(2). 164–175. 2 indexed citations
18.
Lodén, Marie, et al.. (2011). The effect of a corticosteroid cream and a barrier‐strengthening moisturizer in hand eczema. A double‐blind, randomized, prospective, parallel group clinical trial. Journal of the European Academy of Dermatology and Venereology. 26(5). 597–601. 22 indexed citations
19.
20.
Tonstad, Serena, Knut T. Smerud, & Lars H. Høie. (2002). A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects,,,. American Journal of Clinical Nutrition. 76(1). 78–84. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Falko H. Herrmann Breakdown of academic impact, for papers by Marina Pontillo Breakdown of academic impact, for papers by Anne Vincent Breakdown of academic impact, for papers by Domenico Canale Breakdown of academic impact, for papers by A. Marcato Breakdown of academic impact, for papers by Sten Rosberg Breakdown of academic impact, for papers by Jill D. Jacobson Breakdown of academic impact, for papers by Michael S. Goldrich Breakdown of academic impact, for papers by C. Almerighi
Rankless by CCL
2026